Medications
acalabrutinib
Tyrosine Kinase Inhibitors
Approved use in
Mantle Cell Lymphoma
Bortezomib (Velcade)
Proteasome Inhibitors
Approved use in
Mantle Cell Lymphoma
brexucabtagene autoleucel
CAR T-Cell Therapy
Approved use in
Mantle Cell Lymphoma
carboplatin
Chemotherapy Agents
Approved use in
Mantle Cell Lymphoma
cytarabine
Chemotherapy Agents
Approved use in
Mantle Cell Lymphoma
dexamethasone
Systemic Steroids
Approved use in
Mantle Cell Lymphoma
doxorubicin
Chemotherapy Agents
Approved use in
Mantle Cell Lymphoma
ibrutinib
Tyrosine Kinase Inhibitors
Approved use in
Mantle Cell Lymphoma
lenalidomide
Immunomodulatory Agents
Approved use in
Mantle Cell Lymphoma
lisocabtagene maraleucel
CAR T-Cell Therapy
Approved use in
Mantle Cell Lymphoma
methotrexate
Chemotherapy Agents
Approved use in
Mantle Cell Lymphoma
obinutuzumab
Monoclonal Antibodies
Approved use in
Mantle Cell Lymphoma
oxaliplatin
Chemotherapy Agents
Approved use in
Mantle Cell Lymphoma
pirtobrutinib
Tyrosine Kinase Inhibitors
Approved use in
Mantle Cell Lymphoma
rituximab
Monoclonal Antibodies
Approved use in
Mantle Cell Lymphoma
temsirolimus
Targeted Therapies
Approved use in
Mantle Cell Lymphoma
venetoclax
Targeted Therapies
Approved use in
Mantle Cell Lymphoma